Cardiff Oncology Inc (CRDF) USD0.0001

Sell:$4.32Buy:$4.59$0.23 (5.12%)

Prices delayed by at least 15 minutes
Sell:$4.32
Buy:$4.59
Change:$0.23 (5.12%)
Prices delayed by at least 15 minutes
Sell:$4.32
Buy:$4.59
Change:$0.23 (5.12%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 December 2024
James E LevineCFO
Buy
Regular purchase transaction
2,400$5.00$12,000.0067,716
17 December 2024
James E LevineCFO
Buy
Regular purchase transaction
2,752$5.42$14,905.3865,316
16 December 2024
James E LevineCFO
Buy
Regular purchase transaction
2,564$3.83$9,820.1262,564
12 December 2024
Renee P TannenbaumIndependent Director
Buy
Regular purchase transaction
10,000$3.42$34,224.0020,000
11 December 2024
Gary William PaceIndependent Director
Buy
Regular purchase transaction
11,500$2.60$29,900.001,059,376
11 December 2024
Gary William PaceIndependent Director
Buy
Regular purchase transaction
350,115$2.60$910,299.001,047,876

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 December 2024
Gary William PaceIndependent Director
Buy
Regular purchase transaction
350,115$2.60$910,299.001,047,876
12 December 2024
Renee P TannenbaumIndependent Director
Buy
Regular purchase transaction
10,000$3.42$34,224.0020,000
11 December 2024
Gary William PaceIndependent Director
Buy
Regular purchase transaction
11,500$2.60$29,900.001,059,376
17 December 2024
James E LevineCFO
Buy
Regular purchase transaction
2,752$5.42$14,905.3865,316
18 December 2024
James E LevineCFO
Buy
Regular purchase transaction
2,400$5.00$12,000.0067,716

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.